PALUMED S.A. benefits from a well defined network of scientific collaboration in all areas that are essential for sustained development of its activities.

Anne ROBERT (Directrice de recherche au CNRS)
Laboratoire de Chimie de Coordination du CNRS, UPR 8241 Toulouse, France

Jean-Michel LASSALLE (Professeur emeritus)
CRCA, UMR CNRS-Université Paul Sabatier, Toulouse, France

- PALUMED has signed an agreement with the CNRS in 2005 for the development of copper chelators as therapeutic agents for the treatment of Alzheimer’s disease.